Neuroinflammation and Immunity: A New Pharmacological Target in Depression

Title:Neuroinflammation and Immunity: A New Pharmacological Target in Depression

Volume: 15 Issue: 4

Author(s): Rosalia Crupi and Salvatore Cuzzocrea

Affiliation:

Keywords: Immunity, major depressive disorder, neuroinflammation.

Abstract: Major depressive disorder (MDD) is a debilitating illness that affects a significant percentage of the world population. This disorder is associated with diminshed productivity and reduced quality of life; unfortunately the underlying pathophysiological mechanisms are not fully clarified. Recently, several studies have suggested that psychiatric disorders could be considered as inflammatory disorders; nevertheless.. Inflammation is therefore an important biological event that might increase the risk of major depressive episodes, much like the more traditional psychosocial factorsThere is strong evidence that depression involves alterations in multiple aspects of immunity that may contribute to the development or exacerbation of a number of medical disorders and also may play a role in the pathophysiology of depressive symptoms.

This review highlights the role of neuroinflammation and immunity in the pathophysiology of psychiatric disorders such as MDD.

Cite this article as:

Crupi Rosalia and Cuzzocrea Salvatore, Neuroinflammation and Immunity: A New Pharmacological Target in Depression, CNS & Neurological Disorders - Drug Targets 2016; 15 (4) . https://dx.doi.org/10.2174/1871527315666160321105339